nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000643	0.000888	CcSEcCtD
Glycopyrrolate—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000643	0.000888	CcSEcCtD
Glycopyrrolate—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000641	0.000885	CcSEcCtD
Glycopyrrolate—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000636	0.000877	CcSEcCtD
Glycopyrrolate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000631	0.000872	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000631	0.00087	CcSEcCtD
Glycopyrrolate—Oedema—Valsartan—type 2 diabetes mellitus	0.000631	0.00087	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00063	0.000869	CcSEcCtD
Glycopyrrolate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000629	0.000868	CcSEcCtD
Glycopyrrolate—Infection—Valsartan—type 2 diabetes mellitus	0.000626	0.000865	CcSEcCtD
Glycopyrrolate—Rash—Glipizide—type 2 diabetes mellitus	0.000626	0.000864	CcSEcCtD
Glycopyrrolate—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000626	0.000864	CcSEcCtD
Glycopyrrolate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000626	0.000863	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000625	0.000863	CcSEcCtD
Glycopyrrolate—Erythema—Losartan—type 2 diabetes mellitus	0.000625	0.000862	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000623	0.00086	CcSEcCtD
Glycopyrrolate—Oedema—Orlistat—type 2 diabetes mellitus	0.000623	0.00086	CcSEcCtD
Glycopyrrolate—Headache—Glipizide—type 2 diabetes mellitus	0.000622	0.000859	CcSEcCtD
Glycopyrrolate—Palpitations—Metformin—type 2 diabetes mellitus	0.000622	0.000858	CcSEcCtD
Glycopyrrolate—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000621	0.000857	CcSEcCtD
Glycopyrrolate—Infection—Orlistat—type 2 diabetes mellitus	0.000619	0.000854	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000618	0.000854	CcSEcCtD
Glycopyrrolate—Flatulence—Losartan—type 2 diabetes mellitus	0.000616	0.00085	CcSEcCtD
Glycopyrrolate—Tension—Losartan—type 2 diabetes mellitus	0.000613	0.000846	CcSEcCtD
Glycopyrrolate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000613	0.000846	CcSEcCtD
Glycopyrrolate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000612	0.000845	CcSEcCtD
Glycopyrrolate—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000612	0.000845	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000611	0.000843	CcSEcCtD
Glycopyrrolate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000611	0.000843	CcSEcCtD
Glycopyrrolate—Agitation—Irbesartan—type 2 diabetes mellitus	0.00061	0.000842	CcSEcCtD
Glycopyrrolate—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00061	0.000842	CcSEcCtD
Glycopyrrolate—Hypertension—Metformin—type 2 diabetes mellitus	0.000607	0.000838	CcSEcCtD
Glycopyrrolate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000607	0.000838	CcSEcCtD
Glycopyrrolate—Nervousness—Losartan—type 2 diabetes mellitus	0.000607	0.000838	CcSEcCtD
Glycopyrrolate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000605	0.000835	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000605	0.000835	CcSEcCtD
Glycopyrrolate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000604	0.000834	CcSEcCtD
Glycopyrrolate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000604	0.000834	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000602	0.000831	CcSEcCtD
Glycopyrrolate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0006	0.000828	CcSEcCtD
Glycopyrrolate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000596	0.000823	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000595	0.000821	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000593	0.000818	CcSEcCtD
Glycopyrrolate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000592	0.000817	CcSEcCtD
Glycopyrrolate—Nausea—Glipizide—type 2 diabetes mellitus	0.00059	0.000814	CcSEcCtD
Glycopyrrolate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000589	0.000813	CcSEcCtD
Glycopyrrolate—Hypotension—Valsartan—type 2 diabetes mellitus	0.000589	0.000813	CcSEcCtD
Glycopyrrolate—Vision blurred—Losartan—type 2 diabetes mellitus	0.000589	0.000813	CcSEcCtD
Glycopyrrolate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000587	0.000811	CcSEcCtD
Glycopyrrolate—Pain—Gliclazide—type 2 diabetes mellitus	0.000587	0.00081	CcSEcCtD
Glycopyrrolate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000587	0.00081	CcSEcCtD
Glycopyrrolate—Rash—Glimepiride—type 2 diabetes mellitus	0.000584	0.000807	CcSEcCtD
Glycopyrrolate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000584	0.000806	CcSEcCtD
Glycopyrrolate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000583	0.000804	CcSEcCtD
Glycopyrrolate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000582	0.000803	CcSEcCtD
Glycopyrrolate—Headache—Glimepiride—type 2 diabetes mellitus	0.000581	0.000801	CcSEcCtD
Glycopyrrolate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000579	0.000799	CcSEcCtD
Glycopyrrolate—Agitation—Losartan—type 2 diabetes mellitus	0.000574	0.000793	CcSEcCtD
Glycopyrrolate—Oedema—Metformin—type 2 diabetes mellitus	0.000574	0.000793	CcSEcCtD
Glycopyrrolate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000573	0.000791	CcSEcCtD
Glycopyrrolate—Flushing—Ramipril—type 2 diabetes mellitus	0.000571	0.000788	CcSEcCtD
Glycopyrrolate—Infection—Metformin—type 2 diabetes mellitus	0.00057	0.000787	CcSEcCtD
Glycopyrrolate—Insomnia—Valsartan—type 2 diabetes mellitus	0.00057	0.000787	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000566	0.000781	CcSEcCtD
Glycopyrrolate—Insomnia—Orlistat—type 2 diabetes mellitus	0.000564	0.000778	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000563	0.000777	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000563	0.000777	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000561	0.000775	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000561	0.000775	CcSEcCtD
Glycopyrrolate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000561	0.000774	CcSEcCtD
Glycopyrrolate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000558	0.00077	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000555	0.000766	CcSEcCtD
Glycopyrrolate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000555	0.000766	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000555	0.000766	CcSEcCtD
Glycopyrrolate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000553	0.000763	CcSEcCtD
Glycopyrrolate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000553	0.000763	CcSEcCtD
Glycopyrrolate—Palpitations—Losartan—type 2 diabetes mellitus	0.000552	0.000762	CcSEcCtD
Glycopyrrolate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000551	0.00076	CcSEcCtD
Glycopyrrolate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000549	0.000757	CcSEcCtD
Glycopyrrolate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000548	0.000757	CcSEcCtD
Glycopyrrolate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000548	0.000757	CcSEcCtD
Glycopyrrolate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000545	0.000753	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000544	0.000751	CcSEcCtD
Glycopyrrolate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000544	0.00075	CcSEcCtD
Glycopyrrolate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000543	0.000749	CcSEcCtD
Glycopyrrolate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000543	0.000749	CcSEcCtD
Glycopyrrolate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000542	0.000748	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000542	0.000748	CcSEcCtD
Glycopyrrolate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000541	0.000746	CcSEcCtD
Glycopyrrolate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000539	0.000744	CcSEcCtD
Glycopyrrolate—Constipation—Valsartan—type 2 diabetes mellitus	0.000539	0.000744	CcSEcCtD
Glycopyrrolate—Infection—Irbesartan—type 2 diabetes mellitus	0.000538	0.000743	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000538	0.000742	CcSEcCtD
Glycopyrrolate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000537	0.000741	CcSEcCtD
Glycopyrrolate—Hypotension—Metformin—type 2 diabetes mellitus	0.000537	0.000741	CcSEcCtD
Glycopyrrolate—Erythema—Ramipril—type 2 diabetes mellitus	0.000536	0.00074	CcSEcCtD
Glycopyrrolate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000536	0.00074	CcSEcCtD
Glycopyrrolate—Pain—Orlistat—type 2 diabetes mellitus	0.000533	0.000735	CcSEcCtD
Glycopyrrolate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000532	0.000734	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000531	0.000733	CcSEcCtD
Glycopyrrolate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000529	0.00073	CcSEcCtD
Glycopyrrolate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000527	0.000728	CcSEcCtD
Glycopyrrolate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000527	0.000727	CcSEcCtD
Glycopyrrolate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000526	0.000727	CcSEcCtD
Glycopyrrolate—Tension—Ramipril—type 2 diabetes mellitus	0.000526	0.000726	CcSEcCtD
Glycopyrrolate—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000525	0.000724	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000524	0.000723	CcSEcCtD
Glycopyrrolate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000524	0.000723	CcSEcCtD
Glycopyrrolate—Nervousness—Ramipril—type 2 diabetes mellitus	0.00052	0.000718	CcSEcCtD
Glycopyrrolate—Dry mouth—Losartan—type 2 diabetes mellitus	0.00052	0.000718	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000516	0.000712	CcSEcCtD
Glycopyrrolate—Confusional state—Losartan—type 2 diabetes mellitus	0.000514	0.00071	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000513	0.000709	CcSEcCtD
Glycopyrrolate—Somnolence—Metformin—type 2 diabetes mellitus	0.00051	0.000705	CcSEcCtD
Glycopyrrolate—Oedema—Losartan—type 2 diabetes mellitus	0.00051	0.000704	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00051	0.000704	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00051	0.000703	CcSEcCtD
Glycopyrrolate—Infection—Losartan—type 2 diabetes mellitus	0.000507	0.000699	CcSEcCtD
Glycopyrrolate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000506	0.000699	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000506	0.000698	CcSEcCtD
Glycopyrrolate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000505	0.000698	CcSEcCtD
Glycopyrrolate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000501	0.000691	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.0005	0.00069	CcSEcCtD
Glycopyrrolate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000498	0.000688	CcSEcCtD
Glycopyrrolate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000498	0.000687	CcSEcCtD
Glycopyrrolate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000497	0.000685	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000496	0.000684	CcSEcCtD
Glycopyrrolate—Fatigue—Metformin—type 2 diabetes mellitus	0.000495	0.000683	CcSEcCtD
Glycopyrrolate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000495	0.000683	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000493	0.00068	CcSEcCtD
Glycopyrrolate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000493	0.00068	CcSEcCtD
Glycopyrrolate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000493	0.00068	CcSEcCtD
Glycopyrrolate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000492	0.00068	CcSEcCtD
Glycopyrrolate—Agitation—Ramipril—type 2 diabetes mellitus	0.000492	0.00068	CcSEcCtD
Glycopyrrolate—Constipation—Metformin—type 2 diabetes mellitus	0.000491	0.000678	CcSEcCtD
Glycopyrrolate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000486	0.000671	CcSEcCtD
Glycopyrrolate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000486	0.00067	CcSEcCtD
Glycopyrrolate—Rash—Glyburide—type 2 diabetes mellitus	0.000482	0.000665	CcSEcCtD
Glycopyrrolate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000482	0.000665	CcSEcCtD
Glycopyrrolate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000481	0.000665	CcSEcCtD
Glycopyrrolate—Headache—Glyburide—type 2 diabetes mellitus	0.000479	0.000661	CcSEcCtD
Glycopyrrolate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000477	0.000658	CcSEcCtD
Glycopyrrolate—Hypotension—Losartan—type 2 diabetes mellitus	0.000477	0.000658	CcSEcCtD
Glycopyrrolate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000473	0.000654	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000473	0.000653	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00047	0.000648	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000468	0.000646	CcSEcCtD
Glycopyrrolate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000467	0.000645	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000465	0.000641	CcSEcCtD
Glycopyrrolate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000464	0.000641	CcSEcCtD
Glycopyrrolate—Pain—Irbesartan—type 2 diabetes mellitus	0.000463	0.00064	CcSEcCtD
Glycopyrrolate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000463	0.00064	CcSEcCtD
Glycopyrrolate—Insomnia—Losartan—type 2 diabetes mellitus	0.000461	0.000637	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000459	0.000634	CcSEcCtD
Glycopyrrolate—Urticaria—Metformin—type 2 diabetes mellitus	0.000456	0.00063	CcSEcCtD
Glycopyrrolate—Nausea—Glyburide—type 2 diabetes mellitus	0.000454	0.000627	CcSEcCtD
Glycopyrrolate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000454	0.000627	CcSEcCtD
Glycopyrrolate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000454	0.000626	CcSEcCtD
Glycopyrrolate—Somnolence—Losartan—type 2 diabetes mellitus	0.000453	0.000626	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000453	0.000625	CcSEcCtD
Glycopyrrolate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000452	0.000624	CcSEcCtD
Glycopyrrolate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000449	0.00062	CcSEcCtD
Glycopyrrolate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000447	0.000617	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000447	0.000616	CcSEcCtD
Glycopyrrolate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000446	0.000616	CcSEcCtD
Glycopyrrolate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000446	0.000616	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000443	0.000612	CcSEcCtD
Glycopyrrolate—Confusional state—Ramipril—type 2 diabetes mellitus	0.000441	0.000609	CcSEcCtD
Glycopyrrolate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000441	0.000608	CcSEcCtD
Glycopyrrolate—Fatigue—Losartan—type 2 diabetes mellitus	0.00044	0.000607	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000437	0.000604	CcSEcCtD
Glycopyrrolate—Oedema—Ramipril—type 2 diabetes mellitus	0.000437	0.000604	CcSEcCtD
Glycopyrrolate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000436	0.000602	CcSEcCtD
Glycopyrrolate—Pain—Losartan—type 2 diabetes mellitus	0.000436	0.000602	CcSEcCtD
Glycopyrrolate—Constipation—Losartan—type 2 diabetes mellitus	0.000436	0.000602	CcSEcCtD
Glycopyrrolate—Rash—Gliclazide—type 2 diabetes mellitus	0.000433	0.000597	CcSEcCtD
Glycopyrrolate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000432	0.000597	CcSEcCtD
Glycopyrrolate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00043	0.000594	CcSEcCtD
Glycopyrrolate—Headache—Gliclazide—type 2 diabetes mellitus	0.00043	0.000593	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000429	0.000592	CcSEcCtD
Glycopyrrolate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000428	0.000591	CcSEcCtD
Glycopyrrolate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000428	0.000591	CcSEcCtD
Glycopyrrolate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000427	0.000589	CcSEcCtD
Glycopyrrolate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000425	0.000586	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000423	0.000583	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00042	0.00058	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000417	0.000576	CcSEcCtD
Glycopyrrolate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000417	0.000576	CcSEcCtD
Glycopyrrolate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000412	0.000569	CcSEcCtD
Glycopyrrolate—Asthenia—Metformin—type 2 diabetes mellitus	0.000412	0.000569	CcSEcCtD
Glycopyrrolate—Hypotension—Ramipril—type 2 diabetes mellitus	0.000409	0.000564	CcSEcCtD
Glycopyrrolate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000408	0.000563	CcSEcCtD
Glycopyrrolate—Pruritus—Metformin—type 2 diabetes mellitus	0.000406	0.000561	CcSEcCtD
Glycopyrrolate—Urticaria—Losartan—type 2 diabetes mellitus	0.000405	0.000559	CcSEcCtD
Glycopyrrolate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000403	0.000556	CcSEcCtD
Glycopyrrolate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000403	0.000556	CcSEcCtD
Glycopyrrolate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000401	0.000553	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000399	0.000551	CcSEcCtD
Glycopyrrolate—Rash—Valsartan—type 2 diabetes mellitus	0.000398	0.000549	CcSEcCtD
Glycopyrrolate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000397	0.000548	CcSEcCtD
Glycopyrrolate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000396	0.000547	CcSEcCtD
Glycopyrrolate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000396	0.000546	CcSEcCtD
Glycopyrrolate—Headache—Valsartan—type 2 diabetes mellitus	0.000395	0.000545	CcSEcCtD
Glycopyrrolate—Rash—Orlistat—type 2 diabetes mellitus	0.000393	0.000542	CcSEcCtD
Glycopyrrolate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000393	0.000542	CcSEcCtD
Glycopyrrolate—Headache—Orlistat—type 2 diabetes mellitus	0.00039	0.000539	CcSEcCtD
Glycopyrrolate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000389	0.000537	CcSEcCtD
Glycopyrrolate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000389	0.000537	CcSEcCtD
Glycopyrrolate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000385	0.000531	CcSEcCtD
Glycopyrrolate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000383	0.000529	CcSEcCtD
Glycopyrrolate—Dizziness—Metformin—type 2 diabetes mellitus	0.00038	0.000524	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000378	0.000521	CcSEcCtD
Glycopyrrolate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000377	0.00052	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000376	0.000519	CcSEcCtD
Glycopyrrolate—Nausea—Valsartan—type 2 diabetes mellitus	0.000375	0.000517	CcSEcCtD
Glycopyrrolate—Constipation—Ramipril—type 2 diabetes mellitus	0.000374	0.000516	CcSEcCtD
Glycopyrrolate—Nausea—Orlistat—type 2 diabetes mellitus	0.00037	0.000511	CcSEcCtD
Glycopyrrolate—Asthenia—Losartan—type 2 diabetes mellitus	0.000366	0.000505	CcSEcCtD
Glycopyrrolate—Vomiting—Metformin—type 2 diabetes mellitus	0.000365	0.000504	CcSEcCtD
Glycopyrrolate—Rash—Metformin—type 2 diabetes mellitus	0.000362	0.0005	CcSEcCtD
Glycopyrrolate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000362	0.000499	CcSEcCtD
Glycopyrrolate—Pruritus—Losartan—type 2 diabetes mellitus	0.000361	0.000498	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00036	0.000497	CcSEcCtD
Glycopyrrolate—Headache—Metformin—type 2 diabetes mellitus	0.00036	0.000497	CcSEcCtD
Glycopyrrolate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000358	0.000495	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000358	0.000494	CcSEcCtD
Glycopyrrolate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000347	0.000479	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000346	0.000477	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000346	0.000477	CcSEcCtD
Glycopyrrolate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000345	0.000476	CcSEcCtD
Glycopyrrolate—Rash—Irbesartan—type 2 diabetes mellitus	0.000342	0.000472	CcSEcCtD
Glycopyrrolate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000341	0.000471	CcSEcCtD
Glycopyrrolate—Nausea—Metformin—type 2 diabetes mellitus	0.000341	0.000471	CcSEcCtD
Glycopyrrolate—Headache—Irbesartan—type 2 diabetes mellitus	0.000339	0.000469	CcSEcCtD
Glycopyrrolate—Dizziness—Losartan—type 2 diabetes mellitus	0.000337	0.000465	CcSEcCtD
Glycopyrrolate—Vomiting—Losartan—type 2 diabetes mellitus	0.000324	0.000448	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000322	0.000445	CcSEcCtD
Glycopyrrolate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000322	0.000444	CcSEcCtD
Glycopyrrolate—Rash—Losartan—type 2 diabetes mellitus	0.000322	0.000444	CcSEcCtD
Glycopyrrolate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000321	0.000443	CcSEcCtD
Glycopyrrolate—Headache—Losartan—type 2 diabetes mellitus	0.000319	0.000441	CcSEcCtD
Glycopyrrolate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000314	0.000433	CcSEcCtD
Glycopyrrolate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000309	0.000427	CcSEcCtD
Glycopyrrolate—Nausea—Losartan—type 2 diabetes mellitus	0.000303	0.000418	CcSEcCtD
Glycopyrrolate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000289	0.000399	CcSEcCtD
Glycopyrrolate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000278	0.000384	CcSEcCtD
Glycopyrrolate—Rash—Ramipril—type 2 diabetes mellitus	0.000276	0.000381	CcSEcCtD
Glycopyrrolate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000275	0.00038	CcSEcCtD
Glycopyrrolate—Headache—Ramipril—type 2 diabetes mellitus	0.000274	0.000378	CcSEcCtD
Glycopyrrolate—Nausea—Ramipril—type 2 diabetes mellitus	0.00026	0.000359	CcSEcCtD
Glycopyrrolate—CHRM5—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.22e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.19e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	4.15e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.15e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.15e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	4.13e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.11e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.09e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.09e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.08e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	4.08e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.05e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—C3—type 2 diabetes mellitus	4.05e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.04e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.04e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.04e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.04e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.03e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	4.03e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.03e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGT—type 2 diabetes mellitus	4.02e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.99e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.99e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.97e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.96e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.96e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	3.96e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.95e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.95e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LEP—type 2 diabetes mellitus	3.94e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—type 2 diabetes mellitus	3.94e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.92e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.91e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.89e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.86e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.85e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGT—type 2 diabetes mellitus	3.85e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	3.85e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.79e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.78e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	3.78e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LEP—type 2 diabetes mellitus	3.77e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—type 2 diabetes mellitus	3.77e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.77e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.73e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.73e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.71e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.71e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.71e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.7e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	3.7e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.7e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	3.69e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.66e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.66e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	3.59e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.56e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	3.54e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.51e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.51e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.5e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.48e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.47e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.47e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.44e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.43e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.43e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.42e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	3.42e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.42e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.41e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.4e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	3.4e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.39e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.39e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.39e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.37e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.37e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	3.37e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.37e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.36e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.36e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	3.34e-05	0.000121	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.32e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.31e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	3.31e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.31e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.29e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.28e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.27e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.26e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.26e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.25e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.25e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.24e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	3.23e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	3.18e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.17e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.17e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	3.17e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	3.16e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	3.13e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.13e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.12e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.11e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.1e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.1e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.09e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.09e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.06e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.97e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.96e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.96e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.95e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.95e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.93e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.92e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.91e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.88e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	2.85e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	2.84e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	2.82e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	2.78e-05	0.000101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	2.76e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.72e-05	9.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.71e-05	9.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.71e-05	9.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.71e-05	9.84e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.71e-05	9.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—INS—type 2 diabetes mellitus	2.7e-05	9.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	2.7e-05	9.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.69e-05	9.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.68e-05	9.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.68e-05	9.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.67e-05	9.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	2.66e-05	9.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.66e-05	9.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.66e-05	9.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.66e-05	9.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	2.65e-05	9.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	2.65e-05	9.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.63e-05	9.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.63e-05	9.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.62e-05	9.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.62e-05	9.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.62e-05	9.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.59e-05	9.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.53e-05	9.18e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.51e-05	9.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.5e-05	9.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.5e-05	9.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.49e-05	9.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.48e-05	9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.47e-05	8.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.42e-05	8.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.4e-05	8.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.38e-05	8.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.37e-05	8.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	2.37e-05	8.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.37e-05	8.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.37e-05	8.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.36e-05	8.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.34e-05	8.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.34e-05	8.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.3e-05	8.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.27e-05	8.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.27e-05	8.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.26e-05	8.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.24e-05	8.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	2.24e-05	8.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.23e-05	8.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.23e-05	8.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.2e-05	8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.2e-05	7.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.19e-05	7.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.19e-05	7.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.19e-05	7.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.19e-05	7.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.18e-05	7.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	2.18e-05	7.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.18e-05	7.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.17e-05	7.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.17e-05	7.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.16e-05	7.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.16e-05	7.83e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.13e-05	7.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	2.09e-05	7.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.08e-05	7.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.08e-05	7.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.06e-05	7.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.04e-05	7.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.99e-05	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.99e-05	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.98e-05	7.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.98e-05	7.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.96e-05	7.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.96e-05	7.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.95e-05	7.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.91e-05	6.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.87e-05	6.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.87e-05	6.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.87e-05	6.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.85e-05	6.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.83e-05	6.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.71e-05	6.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.7e-05	6.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.69e-05	6.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.68e-05	6.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.68e-05	6.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.68e-05	6.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.67e-05	6.07e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.67e-05	6.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.66e-05	6.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.6e-05	5.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.59e-05	5.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.58e-05	5.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.58e-05	5.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-05	5.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.56e-05	5.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.55e-05	5.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.54e-05	5.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.53e-05	5.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.47e-05	5.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.47e-05	5.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.47e-05	5.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.45e-05	5.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.43e-05	5.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.43e-05	5.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.42e-05	5.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.41e-05	5.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.36e-05	4.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.32e-05	4.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-05	4.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.3e-05	4.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.3e-05	4.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.29e-05	4.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.29e-05	4.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.27e-05	4.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-05	3.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.91e-06	3.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	9.88e-06	3.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.79e-06	3.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.15e-06	3.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.12e-06	3.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.03e-06	3.28e-05	CbGpPWpGaD
